Taho Pharmaceuticals Ltd. (6467)
Market Closed
11 Aug, 05:30
TWSE TWSE Primary NT$
127. 00
+12.5
+10.917%
NT$
7.36B Market Cap
- P/E Ratio
- Div Yield
625,986 Volume
- Eps
NT$ 114.5
Previous Close Want to track 6467 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Taho Pharmaceuticals Ltd. (6467) Statistics
Valuation metrics
Market Cap 7.36B
Enterprise value 7.02B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) 952.63
Price/Book (mrq) 16.32
Enterprise Value/Revenue 902.19
Enterprise Value/EBITDA -41.61
Overview
Shares outstanding 52.36M
Float 35.89M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 428.34K
Average volume (90 days) 366.74K
Price summary
52-Week low 91.1
52-Week high 208.5
Beta -0.2
50-Day moving average 127.58
200-Day moving average 140.07
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.64%
Operating margin -9.7%
Operational effectiveness
Return on assets -0.29%
Return on equity -0.48%
Income Statement
Revenue (ttm) 7.78M
Revenue per share (ttm) 0.16
Quarterly revenue growth (yoy) -
Gross profit (ttm) 4.88M
EBITDA -168.68M
Net income to common (ttm) -165.96M
Diluted EPS (ttm) -4.16
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 401.52M
Total cash per share (mrq) 7.81
Total debt (mrq) 14.01M
Total Debt/Equity (mrq) 3.14
Current ratio (mrq) 35.74%
Book value per share (mrq) 8.67
Cash Flow
Cash flow statement -162.46M
Levered free cash flow (LFCF) -113.17M
